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Peroral endoscopic myotomy is effective and safe
in non-achalasia esophageal motility disorders:
an international multicenter study
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ABSTR AC T

Background and study aims The efficacy of per oral
endoscopic myotomy (POEM) in non-achalasia esophageal
motility disorders such as esophagogastric junction outflow
obstruction (EGJOO), diffuse esophageal spasm (DES), and
jackhammer esophagus (JE) has not been well demonstrated. The aim of this international multicenter study was to
assess clinical outcomes of POEM in patients with nonachalasia disorders, namely DES, JE, and EGJOO, in a large
cohort of patients.
Patients and methods This was a retrospective study at
11 centers. Consecutive patients who underwent POEM for
EGJOO, DES, or JE between 1/2014 and 9/2016 were included. Rates of technical success (completion of myotomy),
clinical response (symptom improvement/Eckardt score ≤
3), and adverse events (AEs, severity per ASGE lexicon)
were ascertained .
Results Fifty patients (56 % female; mean age 61.7 years)
underwent POEM for EGJOO (n = 15), DES (n = 17), and JE (n
= 18). The majority of patients (68 %) were treatment-naïve.
Technical success was achieved in all patients with a mean
procedural time of 88.4 ± 44.7 min. Mean total myotomy
length was 15.1 ± 4.7 cm. Chest pain improved in 88.9 % of
EGJOO and 87.0 % of DES/JE (P = 0.88). Clinical success was
achieved in 93.3 % of EGJOO and in 84.9 % of DES/JE (P =
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0.41) with a median follow-up of 195 and 272 days, respectively. Mean Eckardt score decreased from 6.2 to 1.0 in
EGJOO (P < 0.001) and from 6.9 to 1.9 in DES/JE (P < 0.001).
A total of 9 (18 %) AEs occurred and were rated as mild in
55.6 % and moderate in 44.4 %.

Introduction
Peroral endoscopic myotomy (POEM) was introduced in 2008
by Inoue and colleagues as the endoscopic alternative to laparoscopic Heller myotomy for treatment of achalasia [1]. Multiple studies have been published since then assessing efficacy
and safety of POEM in achalasia patients and have shown excellent clinical response in more than 80 % to 90 % of patients [2 –
7]. In addition, serious adverse events (AEs) are rare and most
AEs can be managed intraprocedurally [8]. More recently,
POEM has been described for treatment of patients with nonachalasia esophageal motility disorders; these include spastic
esophageal disorders, namely diffuse esophageal spam (DES),
jackhammer esophagus (JE), and esophagogastric junction outflow obstruction (EGJOO) [9, 10]. However, the role POEM plays
in management of these disorders is not clear, mainly due to
scarcity of studies on this topic.
DES is characterized by normal mean Integrated Relaxation
Pressure (IRP) and ≥ 20 % premature contractions. JE is an extreme pattern of hypercontractility and is defined manometrically as at least one swallow with a distal contractile integral
(DCI) (the metric of contractile vigor), greater than 8000 mm
Hg-s-cm. EGJOO is defined as an elevated IRP > 15 mmHg with
evidence of peristalsis such that a diagnosis of achalasia is not
met [11].
Medical and endoscopic (e. g. calcium channel blockers and
botulinum toxin injection) therapy of DES and JE is ineffective in
the majority of patients [12, 13]. POEM is potentially an ideal
treatment for these disorders. Spastic contractions can extend
proximally in patients with DES and JE. Extending the myotomy
into the proximal esophagus may not be possible surgically due
to anatomic reasons. A short myotomy may potentially result in
an ineffective procedure. POEM permits easy access to the
proximal and mid-esophagus without limit to the extent of
myotomy. Nonetheless, few reports that included a small number of patients have suggested potential effectiveness of POEM
in DES and JE [9, 14]. The aim of this international multicenter
study was to assess clinical outcomes of POEM in patients with
non-achalasia disorders, namely DES, JE, and EGJOO, in a large
cohort of patients.

Patients and methods
This was a retrospective study at 11 centers (5 North America, 4
Europe, 2 Asia) between January 2014 and September 2016.
Only patients with DES, JE and EGJOO were included. Patients
diagnosed with achalasia, including spastic (type III) subtype,
were excluded. Diagnosis was based on high-resolution mano-
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Conclusion POEM is effective and safe in management of
non-achalasia esophageal motility disorders, which include
DES, JE, and EGJOO.

metric findings according to the Chicago classification of
esophageal motility disorders ( ▶ Fig. 1). Overall, 21 patients
have been reported in previous publications (9 patients [15,
16], 6 patients [16], 5 patients [17], and 1 patient [15]). The
study was approved by the local ethics committees at all participating centers.

Data collection
Relevant patient and procedural data were abstracted by chart
reviews and entered into a de-identified database. Preprocedural data included demographics, type of esophageal motility
disorder, patient symptoms, Eckardt score, duration of disease,
and prior medical, endoscopic and/or surgical therapy. Procedural data included date of procedure, extent (partial or complete) of myotomy, length of esophageal and gastric myotomies, intraprocedural AEs and procedure duration. Post-procedural data included length of hospital study, delayed AEs,
symptoms and Eckardt score, reflux symptoms and medication
(e. g. proton pump inhibitors) usage, and length of follow-up.

Measured outcomes
Technical success was defined as successful completion of
myotomy, while clinical response was defined as symptom improvement and Eckardt score ≤ 3. AEs were recorded and their
severity was graded according to the ASGE lexicon as defined
by Cottton et al. [18]

Procedural technique and periprocedural care
POEM was performed as previously described [19] in patients
with achalasia with the major difference in length of esophageal myotomy. This was determined by the proximal extent of
spastic contractions above the LES as determined by review of
high-resolution esophageal manometric tracings and observation of the esophagus during endoscopy for visible spasms. A
high-definition gastroscope with jet injection capability with a
clear cap mounted on its tip was used for all procedures with
patients under general anesthesia using carbon dioxide for insufflation. A submucosal bleb was then created using saline
and blue dye in the proximal or mid-esophagus above the spastic esophageal segment. A 1.5-cm longitudinal incision was
performed over the bleb using an Endocut Q (ERBE, Tübingen,
Germany) current with either a triangle tip knife (Olympus, Tokyo, Japan) or Hybridknife (ERBE). The gastroscope was then introduced into the submucosal space and submucosal tunneling
was performed using spray-coagulation mode. The tunnel was
extended across the LES and into the gastric cardia. It is unknown if LES and cardia myotomy are essential in patients with
DES and JE as the main pathology possibly does not involve the
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▶ Fig. 1 a High-resolution manometry with findings consistent with jackhammer esophagus (distal contractile integral > 8000 mmHg-s-cm).
b Per oral endoscopic myotomy with long myotomy (17 cm) for management of jackhammer esophagus

LES. However, all operators in the current study performed LES
and cardia myotomy. Following completion of the tunnel,
endoscopic myotomy was commended 2 to 3 cm below the
mucosal incision and extended to the end of the tunnel. Direction (anterior vs posterior) and extent (selective inner circular
vs full-thickness) of myotomy were determined at the treating
endoscopist’s discretion. After completion of myotomy, the
mucosal incision was closed using through-the-scope clips.
All patients received periprocedural antibiotics and were admitted to the hospital for observation. An esophagram was obtained the following day to exclude esophageal leak followed by
commencement of liquid and then soft diet. Patients were discharged home if they were able to tolerate soft diet without
significant pain.

Statistical analysis
Results are reported as mean and standard deviation/range for
quantitative variables while percentages were used for categorical variables. Comparison of continuous variables was performed with the student’s t-test and Mann-Whitney U test and
categorical variables by using the chi-square test and Fisher exact. A level of significance of P < 0.05 was adopted for all inferential testing. Statistical analysis was performed by using SPSS
version 16 (SPSS Inc, Chicago, Ill).

Results
During the study period, 50 patients (56 % female; mean age
61.7 ± 16.3 years) underwent POEM for EGJOO (n = 15), DES (n
= 17), or JE (n = 18) (▶ Table 1). Mean duration of symptoms
was 53.2 ± 84.4 months. The mean preprocedural Eckardt score
was 6.9 ± 2.3. Chest pain was present in 36 patients. The major-

ity of patients with DES/JE were treatment-naïve (77.1 %, n = 27)
while three patients (8.5 %) had pneumatic dilation (PD) alone,
three patients (8.5 %) had previous botulinum injection (BT)
alone, one patient (2.9 %) had previous PD and Heller myotomy,
and one patient (2.9 %) had previous BT and Heller myotomy. As
for EGJOO, nine patients (60 %) were treatment-naïve, four
(26.7 %) had previous PD alone, one (6.6 %) had previous BT
alone, and one patient (6.6 %) had previous BT and PD.
POEM was successfully completed (technical success) in all
50 patients (100 %) with a mean procedural time of 88.4 ± 44.7
minutes. Selective inner circular myotomy was implemented in
48.0 % of patients and full-thickness myotomy in 44.0 % (8.0 %
unspecified). Mean total myotomy length was 15.1 ± 4.7 cm.
Mean length of esophageal myotomy was 12.5 ± 4.3 cm, while
mean length of gastric myotomy was 2.5 ± 1.05 cm. All patients
underwent myotomy of the LES with myotomy extension into
the gastric cardia. All patients were hospitalized after completion of POEM with a median length of hospital stay of 2 days
(IQR 1 – 5). Nine AEs (18 %) (55.6 % mild and 44.4 % moderate)
occurred in 8 patients, including two symptomatic capno-thorax/peritoneum, one bleed, one esophageal leak, one post-procedure pain, one inadvertent mucosotomy, one aspiration
pneumonia, one submucosal hematoma, and one unspecified
(▶ Fig. 2). During a median follow-up duration of 242.5 days
(IQR 40.5 – 505.5), 42 patients (87.5 %) achieved clinical success (2 patients were lost to follow-up) with an Eckardt score
≤ 3. The majority of patients (52 %) had either complete or almost complete (Eckardt score 0 or 1) resolution of symptoms.
Chest pain improved in 87.5 % of patients who had chest pain
prior to POEM. Mean post-procedural Eckardt score was 1.6 ±
2.2. Reflux symptoms developed in 22.2 % of patients, all of
whom were successfully treated with proton pump inhibitors.
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▶ Table 1 Baseline characteristics.
Age (years, mean [SD])

61.7 (16.3)

Gender
Female n = (%)

28 (56.0)

Male n = (%)

22 (44.0)

Duration of symptoms (months, mean [SD])

53.2 (84.4)

Chest pain (missing data = 3) n = (%)

36 (76.6)

None

11 (23.4)

Occasional

13 (27.7)

Daily

11 (23.4)

Each Meal

12 (25.5)

Total Eckardt Score, mean (SD)/median (IQR)

6.9 (2.3)/7 (5 – 8)

Medical therapy (some patients on more than
one) n = (%)

20 (40.0)

Calcium channel blocker (CCB)

16 (32.0)

Nitric oxide

7 (14.0)

Tricyclics

1 (2.0)

Others

2 (4.0)

Endoscopic treatment-naïve n = (%)

36 (72.0)

Prior botulinum toxin injection and pneumatic
dilation n = (%)

1 (2.0)

Prior pneumatic dilation alone n = (%)

7 (14.0)

Prior botulinum toxin injection alone n = (%)

4 (8.0)

Prior pneumatic dilation and Heller myotomy
n = (%)

1(2.0)

Prior botulinum toxin injection and Heller
myotomy n = (%)

1 (2.0)

SD, standard deviation; IQR, interquartile range

Repeat high-resolution esophageal manometry was available in
35 patients and showed resolution of initial manometric abnormalities in 29 (82.9 %). Mean integrated relaxation pressures
(IRP) pre- and post-POEM for EGJOO were 25.5 ± 8.48 mmHg
and 9.6 ± 7.95 mmHg, respectively.

Subgroup analysis
The mean procedural time was 73.9 ± 22.1 minutes in EGJOO
and 94.7 ± 50.5 minutes in DES/JE (P = 0.13). Mean length of
esophageal myotomy was greater in DES/JE at 13.8 ± 4.1 cm
(range: 7 – 23 cm) vs. 9.6 ± 3.5 cm (range: 4 – 17 cm) in EGJOO
(P = 0.001). Myotomy of the lower esophageal sphincter (LES)
was performed in all patients with EGJOO and DES/JE with a
mean gastric myotomy length of 2.93 ± 0.59 cm (range: 2 –
4 cm) and 2.34 ± 1.16 cm (range: 1 – 7 cm), respectively (P =
0.07). Full-thickness myotomy was undertaken in 53.3 % of EGJOO and 40.0 % of DES/JE (P = 0.001), with the remaining patients undergoing selective inner circular myotomy. Chest pain
improved in 88.9 % of EGJOO and 87.0 % of DES/JE (90.9 % in DES
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and 83.3 % in JE) (P = 0.88) (▶ Table 2). Clinical success was
achieved in 93.3 % of EGJOO and in 84.9 % of DES/JE (94.1 % in
DES and 75.0 % in JE, P = 0.41) with a median follow-up of 195
days interquartile range (IQR): 139 – 617 and 272 days IQR:36 –
500, respectively. Mean Eckardt score decreased from 6.2 to
1.0 in EGJOO (P < 0.001) and from 6.9 to 1.9 in DES/JE (6.8 to
1.4 in DES and 7.5 to 2.5 in JE) (P < 0.001). A higher proportion
of patients in the EGJOO group achieved complete or almost
complete (Eckardt score 0 or 1) resolution of symptoms
(60.0 % vs. 48.6 %, P = 0.46). Rates of AEs were comparable between both groups (13.3 % vs 20.0 %, P = 0.58). Post-POEM
symptomatic reflux was also similar (35.7 % vs. 16.1 %, P =
0.15). Median length of hospitalization was 3 days (IQR 1 – 4)
in EGJOO and 2 days (IQR 1.5 – 5.5) in DES/JE.

Discussion
POEM has revolutionized management of achalasia since its inception in 2008 [1]. More than 300 reports have been published to date on POEM, the vast majority of which described
POEM for management of achalasia. In recent years, POEM has
also been introduced for management of non-achalasia esophageal motility disorders [9], but the scarcity of reports has led
to low dissemination and suboptimal knowledge of the role of
POEM in managing these disorders. This multicenter international study assessed efficacy and safety of POEM in management of patients with EGJOO, DES and JE. POEM resulted in clinical success in the majority of patients (87.5 %). Although AEs
occurred in 18 % of patients, 55.6 % were rated as mild and
44.4 % as moderate with no severe events. All complications
could be managed intraprocedurally or with conservative management. There was no need for surgical intervention in any of
the patients. On subgroup analysis, patients with EGJOO had a
numerically higher response rate as compared to patients with
spastic disorders (DES and JE) at 93.3 % and 84.9 %, respectively.
The difference, however, was not statistically significant (P =
0.41), likely a type II error due to the relatively small number
of included patients. Remarkably, chest pain improved in
> 85 % of patients in both groups. Chest pain is frequently the
major presenting symptom in these disorders and is difficult
to treat [20, 21].
A previous multicenter study investigated the role of POEM
in 73 patients with spastic esophageal disorders [9]. However,
the vast majority of patients (n = 54) in that study had type III
(spastic) achalasia. A total of nine patients had DES and 10 had
JE and clinical response was achieved in 100 % and 70 % of patients, respectively. Chest pain significantly improved in 87 %
of patients who reported chest pain before POEM. Results
from the current study along with published data suggest
POEM as an effective technique for these difficult-to-treat spastic disorders. It is important to mention that a long esophageal
myotomy is essential to ensure that proximal esophageal
spasms are effectively covered and treated. Mean length of
esophageal myotomy in patients with DES and JE in the current
study was about 14 cm, which is more than twice the length of a
typical endoscopic or surgical myotomy performed in achalasia
patients.
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AE

Mild (n = 5, 55.6 %)
▪ Inadvertent mucosotomy
▪ Symptomatic
pneumoperitoneum
▪ Aspiration pneumonia
▪ Uncontrolled post-procedure
pain
▪ Other (unspecified)

Severe (0)

Moderate (n = 4, 44.4 %)
▪ Esophageal Leak
▪ Pneumothorax
▪ Delayed bleeding

▶ Fig. 2 Adverse events stratified according to severity as per the ASGE Lexicon [18].

▶ Table 2 Clinical outcomes stratified according to type of esophageal motility disorder.
Outcome

EGJOO

DES/JH

(n = 15)

(m = 35)

P-value

Improvements in chest pain (%, 95 %CI)

88.9 (51.7 – 99.7)

87 (66.4 – 97.2)

0.88

Clinical success (%, 95 %CI)

93.3 (68.1 – 99.8)

84.9 (68.1 – 94.9)

0.41

1.0 (0.55 – 1.68)

1.9 (1.41 – 2.42)

0.24

Mean post POEM Eckardt score, mean (95 % CI)
Post-POEM symptomatic reflux (%, 95 %CI)
Median length of hospitalization (days, IQR)
Median length of follow-up (days, IQR)

35.7 (12.8 – 64.9)
3 (1 – 4)
195 (139 – 617)

16.1 (5.5 – 33.7)

0.14

2 (1.5 – 5.5)

0.85

272 (36 – 500)

0.96

HRM performed post-POEM (%, 95 %CI)

93.3 (68.1 – 99.8)

60 (42.1 – 76.1)

0.02

Resolution of EGJOO/DES/JE on post-procedure HRM (%, 95 %CI)

71.4 (41.9 – 91.6)

90.5 (69.6 – 98.8)

0.14

Adverse events (%, 95 %CI)

13.3 (1.6 – 40.4)

20 (8.4 – 36.9)

0.71

SD, standard deviation; IQR, interquartile range; POEM, per oral endoscopic myotomy; EGJOO, esophagogastric junction outflow obstruction; DES, diffuse esophageal spasm; JE: jackhammer esophagus; HRM, high-resolution manometry

Patients with DES and JE do not typically have EGJ outflow
obstruction [22, 23]. It is arguable whether they require myotomy of the LES. Unfortunately, the necessity of LES myotomy
cannot be inferred from the current study as LES was included
in myotomy in all patients. However, inclusion of the LES seems
warranted by the potential after-effects of myotomy, even in
the setting of normal LES pressure, because preserving LES
pressure may result in postoperative dysphagia caused by induced aperistalsis. Recently, Bechara and colleagues reported
four cases of JE treated with POEM, three of whom had LES
myotomy and one who did not [14]. Patients in whom the LES
was included during POEM had resolution or significant improvement in symptoms. The one patient in whom the LES was
preserved developed significant dysphagia and regurgitation.
Subsequently, this latter patient underwent repeat POEM which
included the LES; this resulted in symptom resolution. The expert authors concluded that myotomy of the LES is advisable
to reduce risk of symptom development from iatrogenic inef-

fective esophageal motility or subsequent progression to achalasia.
EGJOO is characterized by elevated median IRP > 15 mmHg
with sufficient evidence of peristalsis such that criteria for
types I-III achalasia are not met [22, 23]. It is believed to be a
variant of achalasia and that at least some patients with EGJOO
will later progress to having achalasia. An extensive myotomy is
not essential in this disorder. There currently exist no dedicated
studies that have evaluated the role of POEM is this newly defined clinical entity. In the current study, a total of 15 patients
with EGJOO were treated with POEM and clinical success was
achieved in 93 % of patients. This is in line with response rates
reported in patients with achalasia who undergo POEM.
The current study had several limitations. The study included a relatively small number of patients and, thus, comparative
data are prone to type II error. However, the studied disorders
are very rare and the compiled cohort represents the largest of
non-achalasia patients who underwent POEM. The study was
retrospective with inherent limitations due to its design. All pa-
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tients were treated at tertiary institutions with extensive expertise in POEM and management of motility disorders; therefore,
results may not be generalizable. As mentioned above, the value of performing LES myotomy could not be concluded from
the current study.

Conclusion
In conclusion, POEM is effective and safe in management of
non-achalasia esophageal motility disorders, which include diffuse ES, JE, and EJOO. Randomized trials are needed to confirm
the primary role of POEM in management of these disorders.
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